	One stop shop-Integrating 18F-PSMA-1007 and 11C-acetate PET with multiparametric MRI imaging for prostate cancer: A prospective study. J Chin Med Assoc Lin KH, Shen SH, Huang WJ, Wei TC, Liu YM, Peng NJ, Yeh SH, Wang YF. PMID: 41359015 [PubMed - as supplied by publisher]
	The Current and Future Role of MRI and PSMA-PET/CT in Diagnosing Oligometastatic Prostate Cancer. Invest Radiol Scheenen TWJ, Fortuin AS, Oprea-Lager DE, de Rooij M. PMID: 41358937 [PubMed - as supplied by publisher]
	Superior Diagnostic Yield of 18F-rhPSMA-7.3 Compared With 18F-DCFPyL PET/CT for the Detection of Recurrent Prostate Cancer. Clin Nucl Med Jindal S, Manna S, Shetty A, Dehdashti F, Parihar AS. PMID: 41358842 [PubMed - as supplied by publisher]
	Robotic secondary cytoreduction in recurrent ovarian cancer: a tailored approach for kidney transplant recipients. Facts Views Vis Obgyn Russo SA, Oliva R, Certelli C, Ammar S, Palmieri L, Lodoli C, Santullo F, Santoro A, Fagotti A, Scambia G, Gallotta V. PMID: 41358473 [PubMed - as supplied by publisher]
	Long-Pulsed Alexandrite Laser for Scrotal Angiokeratomas: Efficacy and Safety in a Clinical Study. J Cosmet Dermatol Molla A, Alraddadi M. PMID: 41358453 [PubMed - indexed for MEDLINE]
	Effect of radical prostatectomy on anxiety, depression, and quality of life in patients diagnosed with prostate cancer. World J Psychiatry Shen PL, Tian ZL, Liu N, Wu B, Yan XT, Cao XM, Qin SF. PMID: 41357915 [PubMed]
	Serum metabolites with diagnostic potential in prostate cancer and the inhibitory effects of alpha-Tocomonoenol on prostate cancer cells. Front Oncol Shen Y, Liu B, Zhou Y, Lv J, Zhang X, Yang C, Zhang Y, Feng N. PMID: 41357585 [PubMed]
	ELOC(TCEB1)-mutated renal cell carcinoma: a case report and clinicopathological analysis. Front Oncol Zhu Y, Fang M, Wang S. PMID: 41357565 [PubMed]
	Exosomal non-coding RNAs: orchestrators of intercellular crosstalk in the prostate cancer tumor microenvironment. Front Immunol Duan H, Xu B, Luo P, Chen T, Zou J. PMID: 41357241 [PubMed - indexed for MEDLINE]
	Gene signature for response prediction to immunotherapy and prognostic markers in metastatic urothelial carcinoma. Front Immunol Langfelder P, Lin ET, Tsai YT, Cha TL, Shieh GS. PMID: 41357226 [PubMed - indexed for MEDLINE]
	Telomere Length and Clear Cell Renal Cell Carcinoma: Unraveling Causal Mechanisms Through Integrative Genetic and Single-Cell Transcriptomic Analysis. Mediators Inflamm Zhang K, Huang C, Zhou J, Fan K, Ruan M, Xiao Y. PMID: 41357133 [PubMed - indexed for MEDLINE]
	CD45⁺ hybrid circulating cells may reflect tumor-immune interactions and serve as transcriptomic indicators of metastatic potential in prostate cancer. Theranostics Kim BG, Jang Y, Kim MG, Song D, Jung J, Jung J, Yoo A, Lee J, Cho NH, Woo HJ, Kim WH, Shin HY, Kim MS, Han HH, Joung JY. PMID: 41355965 [PubMed - indexed for MEDLINE]
	Masculinity and psychological adjustment in men living with prostate cancer: a systematic review and meta-analysis. Psychol Health Li Y, Finucane A, Golds L, Gillanders D. PMID: 41355523 [PubMed - as supplied by publisher]
	Deciphering Resistance: Beyond the Androgen Paradigm; Report From the 2025 Coffey-Holden Prostate Cancer Academy Meeting. Prostate Stoyanova T, Priceman SJ, Ross AE, Tran PT, McKay RR, Pienta KJ, Soule HR, Miyahira AK. PMID: 41355303 [PubMed - as supplied by publisher]
	Radiomics Reproducibility in Prostate Cancer Diagnosis Based on PROSTATEx. Int Neurourol J Jung S, Kim JS. PMID: 41355262 [PubMed]
	A rapid urinary test for combining PSA and zinc to enhance prostate cancer diagnosis: results from a prospective study. Prostate Cancer Prostatic Dis Amparore D, De Cillis S, Zamengo D, Ortenzi M, Alladio E, Di Nardo F, Serra T, Occhipinti S, Fiori C, Porpiglia F. PMID: 41354696 [PubMed - as supplied by publisher]
	Clinical Trial in Progress: SWOG S2210, a Phase 2 Study of Neoadjuvant Carboplatin for Localized High-risk Prostate Cancer with Germline BRCA1/2 Mutations. Eur Urol Focus Cheng HH, Callis S, Yu EY, Delacroix SE, Sokolova AO, Tangen CM, Lerner SP, Dorff TB, Lin DW. PMID: 41354605 [PubMed - as supplied by publisher]
	Neoadjuvant Systemic Therapy in High-risk Localised Prostate Cancer: Current Evidence and Future Directions. Eur Urol Focus Al-Khanaty A, Hennes D, Perera ML, Lawrentschuk N, Murphy DG, Eapen RS. PMID: 41354604 [PubMed - as supplied by publisher]
	Androgen deprivation therapy with apalutamide in the treatment of metastatic castration-sensitive prostate cancer: the systematic review of its effectiveness and applicability for Asian men in the targeted investigational treatment analysis of novel anti-androgen (TITAN) trial. Int Urol Nephrol Yang F, Feng L, Liu W, Liang S. PMID: 41353294 [PubMed - as supplied by publisher]
	A novel angiogenesis-related gene signature predicting prognosis in clear cell renal cell carcinoma. Sci Rep Xu YY, Cheng GB, Li XY, Zeng XX, Wu SY. PMID: 41353246 [PubMed - as supplied by publisher]

Articles 1 - 20 / 174317

Page 1 of 8716



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy